Trials / Completed
CompletedNCT03316430
Podocyturia as Predictive Factor for Pre-eclampsia
Prospective Study : Podocyturia as Predictive Factor for Pre-eclampsia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Podocyn could be identified in the urine, before proteinuria, a key element in the diagnostic of pre-eclampsia. Preventive treatment using aspirin could be administrated in early pregnancy. We hypothesized that podocyturia could be an early indicator of preeclampsia. This is a prospective, non-interventional, monocentric study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Podocyturia quantification | Podocyturia quantification at first planned prenatal care visit before 16 weeks of gestation |
Timeline
- Start date
- 2019-05-15
- Primary completion
- 2021-12-07
- Completion
- 2021-12-07
- First posted
- 2017-10-20
- Last updated
- 2022-01-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03316430. Inclusion in this directory is not an endorsement.